Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022
November 04, 2021 at 02:00 am EDT
Share
Terumo Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2022. For the year, the company expects revenue to be in the range of JPY 685,000 million, operating profit to be in the range of JPY 120,000 million, profit for the year attributable to the owners of the parent to be in the range of JPY 92,000 million and Basic earnings per share to be in the range of JPY 121.66.
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
TERUMO CORPORATION 
